What is Lumibird S.A.?
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria.
0FRI · Verdict
Moderate reward · elevated risk
0FRI is broadly in line with peers, with profitability the standout concern.
Based on 88% data coverage
0FRI · Verdict
6% net margin · 7% ROE
Model-based scoring. For information only — not financial advice.
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates through Photonics and Medical divisions. The company is listed on the LSE in UK, with a market capitalisation of 345.96M, and a P/E ratio of 1.3x.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.